Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

US10626386B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10626386-B2
Application numberUS-201916273544-A
CountryUS
Kind codeB2
Filing dateFeb 12, 2019
Priority dateSep 17, 2009
Publication dateApr 21, 2020
Grant dateApr 21, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

First claim

Opening claim text (preview).

What is claimed is: 1. A DNA construct or recombinant expression vector comprising an isolated polynucleotide comprising a nucleotide sequence that encodes a GH61 polypeptide having cellulolytic enhancing activity, wherein the isolated polynucleotide is operably linked to one or more heterologous control sequences that direct the production of the polypeptide in an expression host, and wherein the GH61 polypeptide having cellulolytic enhancing activity is selected from: (a) a GH61 polypeptide having at least 95% sequence identity to amino acids 22 to 368 of SEQ ID NO: 10; and (b) a GH61 polypeptide encoded by a polynucleotide having at least 99% sequence identity to nucleotides 64 to 1104 of SEQ ID NO: 9, or a GH61 polypeptide encoded by the cDNA of nucleotides 64 to 1104 of SEQ ID NO: 9. 2. The DNA construct or recombinant expression vector of claim 1 , wherein the GH61 polypeptide has at least 96% sequence identity to amino acids 22 to 368 of SEQ ID NO: 10. 3. The DNA construct or recombinant expression vector of claim 1 , wherein the GH61 polypeptide has at least 97% sequence identity to amino acids 22 to 368 of SEQ ID NO: 10. 4. The DNA construct or recombinant expression vector of claim 1 , wherein the GH61 polypeptide has at least 98% sequence identity to amino acids 22 to 368 of SEQ ID NO: 10. 5. The DNA construct or recombinant expression vector of claim 1 , wherein the GH61 polypeptide has at least 99% sequence identity to amino acids 22 to 368 of SEQ ID NO: 10. 6. The DNA construct or recombinant expression vector of claim 1 , wherein the GH61 polypeptide comprises amino acids 22 to 368 of SEQ ID NO: 10. 7. The DNA construct or recombinant expression vector of claim 1 , wherein the GH61 polypeptide consists of amino acids 22 to 368 of SEQ ID NO: 10. 8. The DNA construct or recombinant expression vector of claim 1 , wherein the GH61 polypeptide is encoded by a polynucleotide comprising nucleotides 64 to 1104 of SEQ ID NO: 9, or the cDNA of nucleotides 64 to 1104 of SEQ ID NO: 9. 9. The DNA construct or recombinant expression vector of claim 1 , wherein the GH61 polypeptide is encoded by a polynucleotide consisting of nucleotides 64 to 1104 of SEQ ID NO: 9, or the cDNA of nucleotides 64 to 1104 of SEQ ID NO: 9. 10. The DNA construct or recombinant expression vector of claim 1 , wherein the GH61 polypeptide is encoded by the polynucleotide contained in pAG68 which is contained in E. coli NRRL B-50320 deposited with the Northern Regional Research Center of the Agriculture Research Service Patent Culture Collection. 11. A recombinant host cell comprising the DNA construct or recombinant expression vector of claim 1 . 12. A method of producing GH61 polypeptide having cellulolytic enhancing activity, said method comprising: (a) cultivating the recombinant host cell of claim 11 under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide. 13. A DNA construct comprising a nucleic acid encoding a signal peptide comprising amino acids 1 to 21 of SEQ ID NO: 10, wherein the nucleic acid is operably linked to a heterologous nucleic acid encoding a protein. 14. A recombinant host cell comprising a nucleic acid encoding a protein, wherein the nucleic acid is operably linked to an isolated polynucleotide encoding a signal peptide comprising amino acids 1 to 21 of SEQ ID NO: 10, wherein the nucleic acid encoding the protein is foreign to the polynucleotide encoding the signal peptide. 15. A method of producing a protein, said method comprising: (a) cultivating the recombinant host cell of claim 14 under conditions conducive for production of the protein; and (b) recovering the protein. 16. A transgenic plant, plant part or plant cell transformed with a polynucleotide encoding a GH61 polypeptide having cellulolytic enhancing activity, wherein the polypeptide comprises a signal peptide directing the polypeptide into the secretory pathway, and wherein the GH61 polypeptide having cellulolytic enhancing activity is selected from: (a) a GH61 polypeptide having at least 95% sequence identity to amino acids 22 to 368 of SEQ ID NO: 10; and (b) a GH61 polypeptide encoded by a polynucleotide having at least 99% sequence identity to nucleotides 64 to 1104 of SEQ ID NO: 9, or a GH61 polypeptide encoded by the cDNA of nucleotides 64 to 1104 of SEQ ID NO: 9. 17. A method of producing a GH61 polypeptide having cellulolytic enhancing activity, said method comprising: (a) cultivating the transgenic plant or plant cell of claim 16 under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide. 18. A method for degrading a cellulosic material comprising: (i) treating the cellulosic material with an enzyme composition comprising a GH61 polypeptide having cellulolytic enhancing activity, and (ii) recovering the degraded cellulosic material; wherein the GH61 polypeptide having cellulolytic enhancing activity is selected from: (a) a GH61 polypeptide having at least 95% sequence identity to amino acids 22 to 368 of SEQ ID NO: 10; and (b) a GH61 polypeptide encoded by a polynucleotide having at least 99% sequence identity to nucleotides 64 to 1104 of SEQ ID NO: 9, or a GH61 polypeptide encoded by the cDNA of nucleotides 64 to 1104 of SEQ ID NO: 9. 19. A method for producing a fermentation product, said method comprising: (i) saccharifying a cellulosic material with an enzyme composition comprising a GH61 polypeptide having cellulolytic enhancing activity; (ii) fermenting the saccharified cellulosic material with one or more fermenting microorganisms to produce the fermentation product; and (iii) recovering the fermentation product from the fermentation; wherein the GH61 polypeptide having cellulolytic enhancing activity is selected from: (a) a GH61 polypeptide having at least 95% sequence identity to amino acids 22 to 368 of SEQ ID NO: 10; and (b) a GH61 polypeptide encoded by a polynucleotide having at least 99% sequence identity to nucleotides 64 to 1104 of SEQ ID NO: 9, or a GH61 polypeptide encoded by the cDNA of nucleotides 64 to 1104 of SEQ ID NO: 9. 20. The method of claim 19 , wherein steps (i) and (ii) are performed simultaneously. 21. A method of fermenting a cellulosic material comprising: (i) fermenting the cellulosic material with one or more fermenting microorganisms, wherein the cellulosic material is saccharified with an enzyme composition comprising a polypeptide having cellulolytic enhancing activity, wherein the fermenting of the cellulosic material produces a fermentation product, and (ii) recovering the fermentation product from the fermentation; wherein the GH61 polypeptide having cellulolytic enhancing activity is selected from: (a) a GH61 polypeptide having at least 95% sequence identity to amino acids 22 to 368 of SEQ ID NO: 10; and (b) a GH61 polypeptide encoded by a polynucleotide having at least 99% sequence identity to nucleotides 64 to 1104 of SEQ ID NO: 9, or a GH61 polypeptide encoded by the cDNA of nucleotides 64 to 1104 of SEQ ID NO: 9.

Assignees

Inventors

Classifications

  • Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

  • hydrolysing O- and S- glycosyl compounds (3.2.1) · CPC title

  • C12N9/2437Primary

    Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150) · CPC title

  • Preparations containing enzymes {, e.g. protease or amylase} · CPC title

  • produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10626386B2 cover?
The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Who is the assignee on this patent?
Novozymes Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/2437. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).